In vivo infusion of anti-LFA-1 and anti-CD2 antibodies prevents graft failure after HLA partially incompatible bone marrow transplantation in children with high risk acute lymphoblastic leukaemia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples